Henk A. Marquering

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Praneeta Konduri

> Home > Persons > Henk A. Marquering

Publications

2023
[j17]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/cmpb/MillerKBLTBSMML23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cmpb/MillerKBLTBSMML23
Claire Miller, Praneeta Konduri, Sara Bridio, Giulia Luraghi, Nerea Arrarte Terreros, Nikki Boodt, Noor Samuels, José F. Rodríguez Matas, Francesco Migliavacca, Hester Lingsma, Aad van der Lugt, Yvo B. W. E. M. Roos, Diederik W. J. Dippel, Henk A. Marquering, Charles B. L. M. Majoie, Alfons G. Hoekstra:
In silico thrombectomy trials for acute ischemic stroke. Comput. Methods Programs Biomed. 228: 107244 (2023)
[j16]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/cmpb/TerrerosRZBMDKKZYLMBMML23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cmpb/TerrerosRZBMDKKZYLMBMML23
Nerea Arrarte Terreros, Silvia Renon, Francesca Zucchelli, Sara Bridio, José Felix Rodriguez Matas, Gabriele Dubini, Praneeta Konduri, Miou S. Koopman, Wim H. van Zwam, Lonneke S. F. Yo, Rob H. Lo, Henk A. Marquering, Ed van Bavel, Charles B. L. M. Majoie, Francesco Migliavacca, Giulia Luraghi:
Microcatheter tracking in thrombectomy procedures: A finite-element simulation study. Comput. Methods Programs Biomed. 234: 107515 (2023)

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.